Clik here to view.
Agilent Announces Thought Leader Award to Dr. Chenli Liu
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Dr. Chenli Liu has been selected to receive an Agilent Thought Leader Award. The award will support his pioneering...
View ArticleClik here to view.
AGCバイオロジクスが特発性肺線維症（IPF）プロジェクトに向け東京慈恵会医科大学とエクソソームについて合意
シアトル （ビジネスワイヤ） — AGCバイオロジクス（バイオ医薬品受託開発・製造（CDMO）のグローバル大手）は、東京慈恵会医科大学と業務委託契約の締結を発表しました。今回の業務委託契約でAGCバイオロジクスは、ミラノにあるCDMOの細胞・遺伝子研究拠点において、特発性肺線維症の治療に焦点を当てた医薬品に関する技術移転と採算性調査を実施します。...
View ArticleClik here to view.
OrganaBio Delivers RUO ＆ GMP LeukoPAC™ Collections to Singapore
MIAMI The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM) in 2015. Although clinical responses...
View ArticleClik here to view.
Syncell Showcases Pioneering Microscopy-Guided Subcellular Protein Scooping...
TAIPEI, Taiwan & LOS ALTOS, Calif. Syncell, a biotech company pioneering in platforms for hypothesis-free spatial proteomics, will be exhibiting and presenting a poster at the AACR Annual...
View ArticleClik here to view.
Genexine’s Long-acting Anemia Treatment GX-E4 Phase 3 Clinical Trial Interim...
SEOUL, South Korea A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase...
View ArticleClik here to view.
CANbridge Pharmaceuticals Spinal Muscular Atrophy Gene Therapy Abstract...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (1228.HK), a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
BeiGene Expands Presence in Latin America With Opening of Brazil Office
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the first major step in the company’s...
View ArticleClik here to view.
China Must Ensure Safety Is Paramount in Biotech Push, says AHF
LOS ANGELES A Washington Post investigation has revealed an ambitious effort by China to expand its biotechnology sector significantly, with sometimes controversial research, to keep up with (or...
View ArticleClik here to view.
MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & SAN MATEO, Calif. & STAMFORD, Conn. MapKure, LLC, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks...
View ArticleClik here to view.
BeiGene and SpringWorks Present Clinical Data on Lifirafenib, in Combination...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & STAMFORD, Conn. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today...
View ArticleClik here to view.
Modalis Therapeutics to Present Data Supporting of Development of...
TOKYO & WALTHAM, Mass. Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative products for the treatment of rare genetic diseases utilizing its...
View ArticleClik here to view.
LifeStrands Genomics and Ambry Genetics to Provide Laboratory Testing for...
SINGAPORE & ALISO VIEJO, Calif. LifeStrands Genomics and Ambry Genetics have joined forces to provide clinical genetic testing services in Singapore. Together, they have been chosen to support...
View ArticleClik here to view.
BeiGene Announces Positive Phase 3 Tislelizumab Trial in Advanced Gastric or...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the global RATIONALE 305 trial met its...
View ArticleClik here to view.
Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented...
FORT LEE, N.J. Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI), Rensselaer, New York, today announced the...
View ArticleClik here to view.
AGC Biologics Received Bioprocessing Excellence Award in Japan
SEATTLE AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has received the “Bioprocessing Excellence in Japan” award at the...
View ArticleClik here to view.
AGCバイオロジクス、バイオプロセッシング・エクセレンス・イン・ジャパンを受賞
シアトル （ビジネスワイヤ） — AGCバイオロジクスは、同社千葉工場での研究成果に対し、「バイオプロセッシング・エクセレンス・イン・ジャパン」賞を受賞したことを発表しました。 IMAPACが主催するAsia-Pacific Bioprocessing Excellence...
View ArticleClik here to view.
アルナイラムとリジェネロン、アルツハイマー病と脳アミロイドアンギオパチーのRNAi治療治験でALN-APPの肯定的な暫定第I相臨床試験データを報告
マサチューセッツ州ケンブリッジ、ニューヨーク州タリータウン （ビジネスワイヤ） –...
View ArticleClik here to view.
EdiGene to Unveil Promising Preclinical POC Data for LEAPER™ 2.0-based in...
BEIJING EdiGene, Inc., a clinical-stage biotechnology company focused on developing transformative gene-editing therapies, announced an oral presentation on the preclinical proof-of-concept (POC)...
View ArticleClik here to view.
CANbridge-UMass Chan Medical School Spinal Muscular Atrophy Gene Therapy...
BURLINGTON, Mass. & BEIJING CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is Tapped by Unipath Specialty...
BOSTON & LAUSANNE, Switzerland SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Unipath...
View Article